Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
HIGH RISK
Score updated Oct 13, 2026

BBLG — Bone Biologics Corporation Dilution Risk Tracker

Track BBLG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BBLG — Get alerts when the score changes →

As of October 13, 2026, Bone Biologics Corporation (BBLG) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Bone Biologics Corporation has a market capitalization of $1.25M, 2.76M shares outstanding, 3 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $1.06M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 20%
🔄 Reverse Split model est. 30%
• 50-day avg $1.26 approaching $1 threshold
💰 Capital Raise model 18%
• Active ATM program with $1M remaining capacity
🔔 Track BBLG — Get forecast alerts →

Market Data

Market Cap$1.25M
Shares Outstanding2.76M
Float1.79M
Cash$6.19M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding2.76MVerified float table or market cache
Public Float1.79MVerified float table or market cache
Market Cap$1.25MMarket data cache
Cash Runway16.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$1.06MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 2, 424B5 1, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↓ 91.4% shares (2026Q1 vs prior)
3 institutional holders · 4.4K shares
#1 Tower Research Capital LLC (TRC) 4.1K shares
#2 SBI Securities Co., Ltd. 230 shares
#3 UBS Group AG 56 shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest49.5K
Days to Cover1.0
% of Float2.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-02
xbrl XBRL CONVERTIBLE 2023-03-30
8-K 8K EVENT 2026-03-13
424B5 ATM 2026-03-13
4 INSIDER TRANSACTION 2026-01-21
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BBLG Dilution Snapshot

Bone Biologics Corporation (BBLG) has a DilutionScore of 52/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BBLG's DilutionScore is currently 52/100 (High risk), with 4 score changes tracked over 89 days. The score improved from 48/100 (Medium risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202652/100HIGH13 days
Sep 14 – Sep 30, 202648/100MEDIUM17 days
Aug 24 – Sep 13, 202647/100MEDIUM21 days
Aug 14 – Aug 23, 202659/100HIGH9 days
Jul 16 – Aug 13, 202644/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track BBLG Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BBLG files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BBLG — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BBLG
BBLG FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.